Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.41Price to Sales
VS
Market
Sector
Industry
History
$ 10.41Close
$ 5.9 - $ 18.13 52-Week Range
Ticker Information
Ticker
NPCECompany Name
NEUROPACE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQNEUROPACE INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NPCE - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 302.03M | 3.41 | $ 88.57M |
| 3/31/2025 | $ 424.74M | 5.04 | $ 84.31M |
| 12/31/2024 | $ 388.12M | 4.86 | $ 79.91M |
| 9/30/2024 | $ 213.12M | 2.79 | $ 76.45M |
| 6/30/2024 | $ 212.55M | 2.96 | $ 71.82M |
| 3/31/2024 | $ 362.48M | 5.25 | $ 69.07M |
| 12/31/2023 | $ 402.49M | 6.15 | $ 65.42M |
| 9/30/2023 | $ 189.24M | 3.14 | $ 60.2M |
| 6/30/2023 | $ 106.02M | 1.93 | $ 54.93M |
| 3/31/2023 | $ 126.77M | 2.61 | $ 48.62M |
Key Performance Insights, Last 5 Years
- NEUROPACE INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, NEUROPACE INC's average P/S has been 3.52.
- The median P/S for NEUROPACE INC during this period was 3.4
- NEUROPACE INC reached its highest P/S over the past 5 years at 6.15.
- The lowest P/S recorded by NEUROPACE INC in the same timeframe 1.44
NEUROPACE INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for NEUROPACE INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 41.14M ]
(=) P/S [ 0 ] NPCE - Price to Sales, Last 5 years
1.44
Minimum
Sep 30, 2022
6.15
Maximum
Dec 31, 2023
3.52
Average
3.4
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |